AssetMark Inc
AST.WS

AssetMark Inc’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History

AssetMark Inc’s Portfolio AST.WS Stock Details AST.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-2
Closed – – 1713
2017
Q2 		$0 Hold
2
– – ﹤0.01% 1569
2017
Q1 		$0 Hold
2
– – ﹤0.01% 1558
2016
Q4 		$0 Hold
2
– – ﹤0.01% 1477
2016
Q3 		$0 Hold
2
– – ﹤0.01% 1332
2016
Q2 		$0 Buy
+2
New +$1 ﹤0.01% 1348

AssetMark Inc's AST.WS Position: Q3 2017 in Review

AssetMark Inc sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 2 shares.

AssetMark Inc first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $0 in Q2 2017. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.

  • AssetMark Inc reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
  • AssetMark Inc sold 2 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
  • AssetMark Inc first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
  • AssetMark Inc's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $0 in Q2 2017.
  • 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.

Based on AssetMark Inc's 13F filing for Q3 2017, filed 8 Nov 2017.